Zcash (ZEC) fluctuates 26.1% in 24 hours: Influencer endorsement triggers short squeeze and renewed privacy demand
Bitget Pulse2026/05/05 21:05Volatility Brief
ZEC experienced dramatic price fluctuations in the past 24 hours, with a low of $416.17 and a high of $524.59. The current price is $523.91, reflecting a significant swing of 26.1%. Trading volume surged notably, reaching $780 million to $800 million USD, a sharp increase compared to usual levels, with clear signs of net capital inflow and active whale buying.
Brief Analysis of Anomaly Causes
- Led by Influencer Endorsements: On May 4, Raoul Pal and Barry Silbert publicly supported ZEC, pushing the price above the $400 mark and triggering over $10 million in short liquidations, which amplified the price surge.
- Trading Volume and Whale Actions: 24-hour trading volume soared to $784 million USD, with intensified whale buying pressure (buy orders 561 vs sell orders 441), strengthening the bullish momentum.
- Ongoing Privacy Narrative: ZEC fee revenue reached $28 million USD; shielded supply and development funds (such as ZODL $25 million) provide background support, though these are not new daily events.
Market Viewpoints & Outlook
Market sentiment has turned bullish, with the community actively discussing the privacy coin revival and ZEC surpassing $400. The Fear & Greed Index stands at 39 (cautious amid fear), with bulls accounting for 68%. Analysts predict a short-term test of the $420-$600 resistance, but caution is advised at the $410 level and regarding BTC dominance (58%); if the $350 support holds, further gains are possible.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.